Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 166 AL 180

Impact of caring for persons with Alzheimer's disease or dementia on caregivers' health outcomes: findings from a community based survey in Japan

Goren A, Montgomery W, Kahle-Wrobleski K, Nakamura T, Ueda K.

BMC Geriatr. 2016 Jun 10;16:122. doi: 10.1186/s12877-016-0298-y.

Aggressiveness of End-of-Life Care for Hospitalized Individuals with Cancer with and without Dementia: A Nationwide Matched-Cohort Study in France

Morin L, Beaussant Y, Aubry R, Fastbom J, Johnell K.

J Am Geriatr Soc. 2016 Sep;64(9):1851-7. doi: 10.1111/jgs.14363. Epub 2016 Jul 26.

Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries

Thorpe CT, Fowler NR, Harrigan K, Zhao X, Kang Y, Hanlon JT, Gellad WF, Schleiden LJ, Thorpe JM.

J Am Geriatr Soc. 2016 Sep;64(9):1806-14. doi: 10.1111/jgs.14403. Epub 2016 Aug 22.

Being brave enough to ask

Bourgeois M.

Can Nurse. 2016 Oct;112(7):2.

Correlation Between Caregiver Reports of Physical Function and Performance-based Measures in a Cohort of Older Adults With Alzheimer Disease

Bernard BL, Bracey LE, Lane KA, Ferguson DY, LaMantia MA, Gao S, Miller DK, Callahan CM.

Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):169-74. doi: 10.1097/WAD.0000000000000101.

Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial

Quintana-Hernández DJ, Miró-Barrachina MT, Ibáñez-Fernández IJ, Pino AS, Quintana-Montesdeoca MP, Rodríguez-de Vera B, Morales-Casanova D, Pérez-Vieitez Mdel C, Rodríguez-García J, Bravo-Caraduje N.

J Alzheimers Dis. 2016;50(1):217-32. doi: 10.3233/JAD-143009.

Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial

Hoffmann K, Sobol NA, Frederiksen KS, Beyer N, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jacobsen S, Laugesen LP, Gergelyffy RG, Høgh P, Bjerregaard E, Andersen BB, Siersma V, Johannsen P, Cotman CW, Waldemar G, Hasselbalch SG.

J Alzheimers Dis. 2016;50(2):443-53. doi: 10.3233/JAD-150817.

Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease

Ibarria M, Alegret M, Valero S, Morera A, Guitart M, Cañabate P, Moreno M, Lara S, Diego S, Hernández J, Tantinyá N, Vera M, Hernández I, Becker JT, Ruíz A, Boada M, Tárraga L.

J Alzheimers Dis. 2016;50(2):559-66. doi: 10.3233/JAD-150455.

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer's disease: a prospective, open-label pilot study

Ohnuma T, Toda A, Kimoto A, Takebayashi Y, Higashiyama R, Tagata Y, Ito M, Ota T, Shibata N, Arai H.

Clin Interv Aging. 2016 Jan 8;11:29-36. doi: 10.2147/CIA.S95362. eCollection 2016.

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease

Cummings JL, Zhong K, Kinney JW, Heaney C, Moll-Tudla J, Joshi A, Pontecorvo M, Devous M, Tang A, Bena J.

Alzheimers Res Ther. 2016 Jan 29;8:4. doi: 10.1186/s13195-016-0173-2.

Opportunities and challenges in developing relevant animal models for Alzheimer's disease

De Felice FG, Munoz DP.

Ageing Res Rev. 2016 Mar;26:112-4. doi: 10.1016/j.arr.2016.01.006. Epub 2016 Jan 30.

Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease

Boccardi V, Ruggiero C, Patriti A, Marano L.

J Alzheimers Dis. 2016;50(4):947-55. doi: 10.3233/JAD-150931.

Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients

Lee YM, Park JM, Lee BD, Moon E, Jeong HJ, Chung YI, Kim JH, Kim HJ, Mun CW, Kim TH, Kim YH.

J Clin Psychiatry. 2016 Jan;77(1):e8-13. doi: 10.4088/JCP.14m09740.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias